# The Effect of an Adhesive Overlay on the Delivery of Contraceptive Hormones From ORTHO EVRA® in Healthy Women

> **NCT01535820** · PHASE1 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 54 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Treatment A: ORTHO EVRA patch (NGMN + EE) with an adhesive overlay
- **DRUG:** Treatment B: ORTHO EVRA patch (NGMN + EE) without an overlay

## Key facts

- **NCT ID:** NCT01535820
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2013-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01535820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01535820, "The Effect of an Adhesive Overlay on the Delivery of Contraceptive Hormones From ORTHO EVRA® in Healthy Women". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01535820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*